{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:05:59Z","timestamp":1784027159784,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.schres.2021.02.012","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T05:04:39Z","timestamp":1615093479000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study"],"prefix":"10.1016","volume":"230","author":[{"given":"Tomasz","family":"Pawe\u0142czyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Grancow-Grabka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"\u017burner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Pawe\u0142czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2021.02.012_bb0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fpsyt.2020.00359","article-title":"Metabolic syndrome and cognitive functions in schizophrenia-implementation of dietary intervention","volume":"11","author":"Adamowicz","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"16","key":"10.1016\/j.schres.2021.02.012_bb0010","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.schres.2021.02.012_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.02.012","article-title":"Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update","volume":"58","author":"Albracht-Schulte","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.schres.2021.02.012_bb0020","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.dsx.2019.07.001","article-title":"Effect of Omega-3 and vitamin E co-supplementation on serum lipids concentrations in overweight patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Asbaghi","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.schres.2021.02.012_bb0025","doi-asserted-by":"crossref","first-page":"111903","DOI":"10.1016\/j.ejmech.2019.111903","article-title":"Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome","volume":"186","author":"Bagetta","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.schres.2021.02.012_bb0026","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.numecd.2014.08.003","article-title":"Docosahexaenoic acid-enriched canola oil increases adiponectin concentrations: a randomized crossover controlled intervention trial","volume":"25","author":"Baril-Gravel","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.schres.2021.02.012_bb0031","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plefa.2012.05.005","article-title":"Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells","volume":"87","author":"Bentsen","year":"2012","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"10.1016\/j.schres.2021.02.012_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/joim.12329","article-title":"Higher mortality after myocardial infarction in patients with severe mental illness: a nationwide cohort study","volume":"277","author":"Bod\u00e9n","year":"2015","journal-title":"J. Intern. Med."},{"issue":"16","key":"10.1016\/j.schres.2021.02.012_bb0035","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","article-title":"Effects of n\u22123 fatty acid supplements in diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.schres.2021.02.012_bb0041","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: From molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.schres.2021.02.012_bb0040","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/j.1440-1614.2006.01869.x","article-title":"Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine","volume":"40","author":"Caniato","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2021.02.012_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/03007995.2017.1419946","article-title":"Cardiometabolic comorbidities and life expectancy in people on medication for schizophrenia in Australia","volume":"34","author":"Castle","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"issue":"7","key":"10.1016\/j.schres.2021.02.012_bb0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S2213-8587(15)00127-8","article-title":"Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study","volume":"3","author":"Chambers","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"17","key":"10.1016\/j.schres.2021.02.012_bb0055","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1080\/10408398.2015.1130016","article-title":"Polyunsaturated fatty acids and type 2 diabetes: impact on the glycemic control mechanism","volume":"57","author":"Coelho","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"10.1016\/j.schres.2021.02.012_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-277X.2012.01240.x","article-title":"Development, reproducibility and validity of the food frequency questionnaire in the Poland arm of the Prospective Urban and Rural Epidemiological (PURE) study","volume":"25","author":"Dehghan","year":"2012","journal-title":"J. Hum. Nutr. Diet."},{"issue":"3","key":"10.1016\/j.schres.2021.02.012_bb0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psychres.2007.06.029","article-title":"Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial","volume":"161","author":"Emsley","year":"2008","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2021.02.012_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2008-2231-20-43","article-title":"Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial","volume":"20","author":"Faghihi","year":"2012","journal-title":"Daru"},{"key":"10.1016\/j.schres.2021.02.012_bb0076","doi-asserted-by":"crossref","first-page":"112522","DOI":"10.1016\/j.psychres.2019.112522","article-title":"Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia","volume":"281","author":"Fang","year":"2019","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2021.02.012_bb0077","first-page":"955","article-title":"Measured versus calculated LDL-cholesterol in subjects with type 2 diabetes","volume":"32","author":"Fawwad","year":"2016","journal-title":"Pak. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.schres.2021.02.012_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3371\/CSRP.FEBR.012513","article-title":"N\u22123 fatty acids for hypertriglyceridemia in patients taking second-generation antipsychotics","volume":"7","author":"Fetter","year":"2013","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"3","key":"10.1016\/j.schres.2021.02.012_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/104012371502700306","article-title":"Omega-3 fatty acids for atypical antipsychotic-associated hypertriglyceridemia","volume":"27","author":"Freeman","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2021.02.012_bb0085","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m12007","article-title":"Metabolic syndrome and illness severity predict relapse at 1-year follow-up in schizophrenia: the FACE-SZ cohort","volume":"79","author":"Godin","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"17","key":"10.1016\/j.schres.2021.02.012_bb0090","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.schres.2021.02.012_bb0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorthoj","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2021.02.012_bb0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/S095442241600007X","article-title":"Current evidence on the association of the metabolic syndrome and dietary patterns in a global perspective","volume":"29","author":"Hosseini","year":"2016","journal-title":"Nutr. Res. Rev."},{"issue":"2","key":"10.1016\/j.schres.2021.02.012_bb0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jacl.2017.01.011","article-title":"The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes","volume":"11","author":"Jamilian","year":"2017","journal-title":"J. Clin. Lipidol."},{"issue":"3","key":"10.1016\/j.schres.2021.02.012_bb0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clnu.2019.03.032","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: a systematic review and meta-analysis","volume":"39","author":"Jang","year":"2020","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.schres.2021.02.012_bb0116","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4103\/2230-8210.137496","article-title":"LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database","volume":"18","author":"Kannan","year":"2014","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.schres.2021.02.012_bb0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14797\/mdcj-15-3-171","article-title":"Recent clinical trials shed new light on the cardiovascular benefits of omega-3 fatty acids","volume":"15","author":"Kris-Etherton","year":"2019","journal-title":"Methodist Debakey Cardiovasc. J."},{"issue":"6","key":"10.1016\/j.schres.2021.02.012_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067133","article-title":"Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries","volume":"8","author":"Laursen","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.schres.2021.02.012_bb0125","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1039\/C9FO00323A","article-title":"Effect of low-ratio n\u22126\/n\u22123 PUFA on blood glucose: a meta-analysis","volume":"10","author":"Li","year":"2019","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.schres.2021.02.012_bb0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/ajcn\/nqy120","article-title":"Effect of combined use of a low-carbohydrate, high-protein diet with omega-3 polyunsaturated fatty acid supplementation on glycemic control in newly diagnosed type 2 diabetes: a randomized, double-blind, parallel-controlled trial","volume":"108","author":"Liu","year":"2018","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.schres.2021.02.012_bb0135","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/jcmm.13453","article-title":"European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus","volume":"22","author":"Luo","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.schres.2021.02.012_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2021.02.012_bb0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2014a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.02.012_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.schres.2018.05.035","article-title":"Correlates of risk factors for reduced life expectancy in schizophrenia: is it possible to develop a predictor profile?","volume":"201","author":"Moradi","year":"2018","journal-title":"Schizophr. Res."},{"issue":"14","key":"10.1016\/j.schres.2021.02.012_bb0155","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.schres.2021.02.012_bb0160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/nutrit\/nuy022","article-title":"Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease","volume":"76","author":"Musa-Veloso","year":"2018","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.schres.2021.02.012_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12888-015-0473-2","article-title":"Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods","volume":"15","author":"Pawelczyk","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2021.02.012_bb0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpsychires.2015.11.013","article-title":"A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia","volume":"73","author":"Pawelczyk","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.schres.2021.02.012_bb0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.schres.2021.02.012_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx","article-title":"Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications","volume":"20","author":"Penninx","year":"2018","journal-title":"Dialogues Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2021.02.012_bb0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ajmg.b.32712","article-title":"Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome","volume":"180","author":"Postolache","year":"2019","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2021.02.012_bb0190","first-page":"S94","article-title":"The metabolic syndrome in untreated schizophrenia patients: prevalence and putative mechanisms","volume":"25","author":"Reddy","year":"2013","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.schres.2021.02.012_bb0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2018.09.006","article-title":"A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: results from a 16week randomized placebo-controlled trial for participants concurrently treated with risperidone","volume":"204","author":"Robinson","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.02.012_bb0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2018.02.047","article-title":"Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - baseline and two-years findings from the CHANGE trial","volume":"199","author":"Storch Jakobsen","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2021.02.012_bb0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12933-018-0766-0","article-title":"Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?","volume":"17","author":"Tenenbaum","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.schres.2021.02.012_bb0211","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fpsyt.2018.00744","article-title":"Metabolic syndrome in psychotic disorder patients treated with oral and long-acting injected antipsychotics","volume":"9","author":"Ventriglio","year":"2018","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2021.02.012_bb0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12944-019-1048-x","article-title":"A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial","volume":"18","author":"Wang","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.schres.2021.02.012_bb0215","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00213-018-5136-9","article-title":"Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial","volume":"236","author":"Xu","year":"2019","journal-title":"Psychopharmacology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:41:27Z","timestamp":1760298087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":50,"alternative-id":["S0920996421000827"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.02.012","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}